Identification of proteins that interact with murine cytomegalovirus early protein M112-113 in brain

Hui Wang1, Xing-Lou Liu, Sai-Nan Shu

  • 1Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.

Chinese Medical Journal
|February 21, 2012
PubMed
Abstract

Insights

Murine cytomegalovirus (MCMV) protein M112-113 interacts with metastasis-associated 1 (MTA1) and ZCCHC18. These interactions may contribute to MCMV-associated central nervous system disease pathogenesis.

Area of Science:

  • Virology
  • Neuroscience
  • Molecular Biology

Background:

  • Murine cytomegalovirus (MCMV) early protein M112-113 is crucial for viral DNA replication and pathogenesis.
  • Cytomegalovirus (CMV) can cause brain disorders, but the role of M112-113 in this process is unclear.

Purpose of the Study:

  • To investigate the biological function of MCMV M112-113 protein in the pathogenesis of CMV-induced brain disorders.
  • To identify proteins that interact with M112-113 using a yeast two-hybrid system.

Main Methods:

  • Constructed bait plasmid pGBKT7-M112-113 and transformed into AH109 yeast.
  • Screened a mouse brain cDNA library for interacting proteins using yeast two-hybrid assay.
  • Verified interactions via yeast two-hybrid and chemiluminescent co-immunoprecipitation in yeast and mammalian cells.

Main Results:

  • Identified two interacting proteins: metastasis-associated 1 (MTA1) and zinc finger, CCHC domain containing 18 (ZCCHC18).
  • Confirmed M112-113 interacts with MTA1 and ZCCHC18 in both yeast and mammalian cells.

Conclusions:

  • The interactions between MCMV M112-113 and MTA1 or ZCCHC18 are potentially linked to the pathogenesis of MCMV-associated central nervous system diseases.